This page shows the latest Active Ownership Capital news and features for those working in and with pharma, biotech and healthcare.
Bain Capital and Cinven's planned buyout of Germany's Stada has failed at the last hurdle, with too few of Stada's shareholders agreeing to the deal by the deadline. ... The private equity bids came after a protracted period of pressure from rebel
Cinven and Bain Capital made what Stada said was the "most financially appealing offer" of 66 per share, topping an earlier bid from Advent International of 58. ... For months, Stada has been under pressure from rebel investor Active Ownership Capital
It has also emerged that the two-horse race has attracted another runner, with a third, non-binding offer from an unnamed company - rumoured to be Bain Capital - matching Advent's ... For months, Stada has been under pressure from rebel investor Active
Other private equity groups, including Advent, Bain Capital, CVC Capital Partners and Permira, have also been rumoured to have an interest in buying the German company, while Polish generic drug company ... The rebel investors - led by Active Ownership
Earlier this year a group called Active Ownership Capital acquired a minority (5%) stake in Stada and has been pushing for the accession of new supervisory board members more amenable to ... Adding to the intrigue, it has been reported that Stada has
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
No results were found
We live in a hyper-connected world. This has clear benefits for the health of our communities, our businesses and our...